Replimune Group, Inc. (REPL) SEC Filings — 2024
35 SEC filings for Replimune Group, Inc. (REPL) in 2024.
Filings
- Replimune Group Files 8-K/A Amendment — 8-K/A · Dec 4, 2024
- Replimune Group Files 8-K — 8-K · Nov 27, 2024
- Replimune Strikes $1.85B+ Oncology Deal — 8-K · Nov 26, 2024
- Replimune Group Files 8-K — 8-K · Nov 21, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Replimune Group Files 8-K on Financials — 8-K · Nov 12, 2024
- Replimune Reports Q2 Loss, R&D Expenses Rise — 10-Q · Nov 12, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Oct 7, 2024
- Replimune Group Reports on Shareholder Vote Matters — 8-K · Sep 5, 2024
- Replimune to Acquire Aura BioSciences for $350M — 8-K · Aug 8, 2024
- Replimune Group Files Q1 FY25 10-Q — 10-Q · Aug 8, 2024
- Replimune Files Definitive Proxy Statement for 2024 Shareholder Meeting — DEF 14A · Jul 19, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Jul 10, 2024
- Replimune Group Enters Definitive Agreement, Discloses Equity Sales — 8-K · Jun 13, 2024
- Replimune Closes $300M Public Offering — 8-K · Jun 6, 2024
- Replimune Group Files 8-K with Corporate Details — 8-K · Jun 3, 2024
- Replimune Group Files 8-K on Financials — 8-K · May 16, 2024
- Replimune Group, Inc. Files 2024 10-K — 10-K · May 16, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Apr 10, 2024
- Replimune Appoints New CMO and CDO, Chief Medical Officer Departs — 8-K · Mar 26, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Replimune Group, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Morgan Stanley Discloses 5.0% Stake in Replimune Group (REPL) — SC 13G · Feb 9, 2024
- Replimune Files 8-K on Financial Results & Operations — 8-K · Feb 8, 2024
- Replimune Group, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 8, 2024
- BlackRock Amends Replimune Stake, Remains Passive Investor — SC 13G/A · Jan 26, 2024
- State Street Discloses Passive Stake in Replimune Group — SC 13G · Jan 25, 2024
- Baker Bros. Advisors LP Maintains Significant Stake in Replimune — SC 13G/A · Jan 10, 2024
- Replimune Files 8-K for Rule 425 Communications — 8-K · Jan 8, 2024